Raynor Pharma Private Limited - Company Profile

It is a trading private limited company based in Sanand, Gujarat, India, established in 2020.
2020 Sanand, Gujarat, India Active
Last Updated:
Access Report
About Raynor Pharma Private Limited

Raynor Pharma Private Limited, a active private limited company, was established on 03 December 2020 in Sanand, Gujarat, India. Engaging in specialty within the trading sector, it holds CIN: U51909GJ2020PTC118624. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Amit Ostawal (Director), Babu Lal Ostawal (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1 New Ahmedabad East Opp. Kalpvijay Engi. Moriya ,, Sanand, Gujarat, 382213.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909GJ2020PTC118624

  • Registration Number

    118624

  • Incorporation Date

    03 December 2020

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 5 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Raynor Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Raynor Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Raynor Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Amit Ostawal Director 03 Dec 2020 Current
Babu Lal Ostawal Director 03 Dec 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Raynor Pharma.

Enhance accessibility to Raynor Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Raynor Pharma revenue growth over time
Raynor Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Raynor Pharma?

Unlock access to Raynor Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Raynor Pharma?

Raynor Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raynor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raynor Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Raynor Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Raynor Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Raynor Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    Amit Ostawal was appointed as a Director was appointed as a Director on 03 Dec 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.

  • Director Appointment

    Babu Lal Ostawal was appointed as a Director was appointed as a Director on 03 Dec 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Raynor Pharma Private Limited was registered on 03 Dec 2020 with Roc Ahmedabad & aged 5 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Raynor Pharma Private Limited?

The CIN of Raynor Pharma Private Limited is U51909GJ2020PTC118624.

Where is Raynor Pharma Private Limited headquartered?

Raynor Pharma Private Limited is headquartered at 1 New Ahmedabad East Opp. Kalpvijay Engi. Moriya ,, Sanand, Gujarat, 382213.

When was Raynor Pharma Private Limited incorporated?

Raynor Pharma Private Limited was incorporated on 03 December 2020.

Who are the current directors of Raynor Pharma Private Limited?

The current directors of Raynor Pharma Private Limited are

What is the primary industry of Raynor Pharma Private Limited?

The primary industry of Raynor Pharma Private Limited is Trading.

Is Raynor Pharma Private Limited a listed company?

Raynor Pharma Private Limited is unlisted.

What is the capital structure of Raynor Pharma Private Limited?

The authorized capital of Raynor Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available